![]() ![]() © American Association for Clinical Chemistry 2021. The ACCU-CHEK Inform II system was evaluated at 2 cutoff boundaries: boundary 1 was 95 of results within ☑2 mg/dL of the reference (samples with blood glucose <75 mg/dL) or ☑2 of the reference (glucose 75 mg/dL), and boundary 2 was 98 of results within ☑5 mg/dL or ☑5 of the reference. The ACCU-CHEK Inform II system demonstrated clinically acceptable performance against the PCA-HK reference method for blood glucose monitoring in a diverse population of critically ill patients in US care settings.īlood glucose blood glucose monitoring blood sugar in intensive care unit critical care laboratory performance evaluation point of care testing. If the patient hand seems clean there is no need to clean the finger furtherd. ![]() An antiseptic wipe and make sure the site is completely dryb. Clinical evaluation demonstrated high specificity and sensitivity, with low risk of potential insulin-dosing errors. 1 / 27 Flashcards Learn Test Match Created by Atils607 Terms in this set (27) list 10 important rules/ procedures for using a glucometer Sample size - 0.6 microliters and applied to FRONT EDGE of strip Testing time - 5 seconds Linear range is 0.6mmol/L-33. Before performing a capillary blood glucose test, what should be used to clean thepuncture site to obtain the best result a. Proportions of results within evaluation boundaries 1 and 2, respectively, were 96% and 98% for venous samples, 94% and 97% for pediatric and adult arterial samples, 84% and 98% for neonatal arterial samples, and 96% and 100% for neonatal heel-stick samples. Clinical performance was assessed by evaluating sample data using Parkes error grid, Monte Carlo simulation, and sensitivity and specificity analyses to estimate clinical accuracy and implications for insulin dosing when using the ACCU-CHEK Inform II system. ![]() II Blood Glucose Monitoring System and answer the following questions. The ACCU-CHEK Inform II system was evaluated at 2 cutoff boundaries: boundary 1 was ≥95% of results within ☑2 mg/dL of the reference (samples with blood glucose <75 mg/dL) or ☑2% of the reference (glucose ≥75 mg/dL), and boundary 2 was ≥98% of results within ☑5 mg/dL or ☑5% of the reference. Name: Lawson : ACCU-CHEK INFORM II TEST COMPETENCY Please read the Guidelines of. Overall, 476 arterial (376 pediatric/adult, 100 neonate), 375 venous, and 100 neonatal heel-stick whole-blood samples were collected and evaluated from critical care settings at 10 US hospitals, including the emergency department, medical and surgical intensive care units (ICUs), and neonatal and pediatric ICUs. Our purpose was to evaluate the performance of the ACCU-CHEK® Inform II blood glucose monitoring system (Roche Diagnostics GmbH) compared with the perchloric acid hexokinase (PCA-HK) comparator method on the cobas® 6000 analyzer (Roche Diagnostics International Ltd) in critically ill patients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |